Regardless of the oncogene used, the presence of inactivating mutations of tumor suppressors or other genetic modifiers, these transgenic models use the promoter of the tyrosinase (tyr) gene, which is expressed in melanocytes, but not in their progenitors, thus practically selecting the population of cells to transform. Here, TYR is linked to neoplasm.